Nyxoah (NYXH) Competitors

Nyxoah (NASDAQ:NYXH) and SI-BONE (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.

Which has higher valuation & earnings, NYXH or SIBN?

SI-BONE has higher revenue and earnings than Nyxoah. SI-BONE is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$4.36M	63.25	-$46.77M	-$2.13	-3.80
SI-BONE	$176.60M	4.66	-$43.34M	-$0.64	-30.16

Do analysts recommend NYXH or SIBN?

Nyxoah presently has a consensus target price of $14.50, suggesting a potential upside of 78.92%. SI-BONE has a consensus target price of $22.50, suggesting a potential upside of 16.55%. Given Nyxoah's higher probable upside, equities research analysts clearly believe Nyxoah is more favorable than SI-BONE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility & risk, NYXH or SIBN?

Nyxoah has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Comparatively, SI-BONE has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.

Does the MarketBeat Community prefer NYXH or SIBN?

SI-BONE received 133 more outperform votes than Nyxoah when rated by MarketBeat users. However, 73.68% of users gave Nyxoah an outperform vote while only 69.17% of users gave SI-BONE an outperform vote.

Company	Underperform	Outperform
Nyxoah	Outperform Votes 42 73.68%	Underperform Votes 15 26.32%
SI-BONE	Outperform Votes 175 69.17%	Underperform Votes 78 30.83%

Do institutionals and insiders believe in NYXH or SIBN?

98.1% of SI-BONE shares are held by institutional investors. 17.1% of Nyxoah shares are held by company insiders. Comparatively, 4.0% of SI-BONE shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the media prefer NYXH or SIBN?

In the previous week, SI-BONE had 10 more articles in the media than Nyxoah. MarketBeat recorded 17 mentions for SI-BONE and 7 mentions for Nyxoah. SI-BONE's average media sentiment score of 1.20 beat Nyxoah's score of 0.07 indicating that SI-BONE is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nyxoah	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SI-BONE	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is NYXH or SIBN more profitable?

SI-BONE has a net margin of -23.82% compared to Nyxoah's net margin of -1,043.93%. SI-BONE's return on equity of -22.51% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-1,043.93%	-51.68%	-40.11%
SI-BONE	-23.82%	-22.51%	-16.53%

Summary

SI-BONE beats Nyxoah on 10 of the 16 factors compared between the two stocks.